Cambridge, Massachusetts & Chicago, U.S.A. 19 December, 2023. Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, and EVERSANA®, a leading provider of commercialization services to the life science industry, today announced the commercial launch of JYLAMVO […]